Entrada Therapeutics OverviewEntrada Therapeutics Other Income Expense Net
Other Income/Expense Net for TRDA.
Quarterly Other Income/Expense
$2.62M
↓ 40.91% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$13.26M
↓ 32.72% YoY
Trailing 12 months ending Mar 31, 2026